TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 33nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 45nMT: 2°CAssay Description:Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay....More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 47nMT: 2°CAssay Description:Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay....More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 79nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 126nMT: 2°CAssay Description:Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay....More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 187nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 230nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 263nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 287nMT: 2°CAssay Description:Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay....More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 518nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 562nMT: 2°CAssay Description:Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay....More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 829nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 1.27E+3nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 1.81E+3nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 3.77E+3nMT: 2°CAssay Description:Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay....More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 4.70E+3nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: 1.44E+4nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
University Of Utah Research Foundation
US Patent
University Of Utah Research Foundation
US Patent
Affinity DataIC50: >1.00E+5nMT: 2°CAssay Description:The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentratio...More data for this Ligand-Target Pair